JPH0435467B2 - - Google Patents

Info

Publication number
JPH0435467B2
JPH0435467B2 JP57192022A JP19202282A JPH0435467B2 JP H0435467 B2 JPH0435467 B2 JP H0435467B2 JP 57192022 A JP57192022 A JP 57192022A JP 19202282 A JP19202282 A JP 19202282A JP H0435467 B2 JPH0435467 B2 JP H0435467B2
Authority
JP
Japan
Prior art keywords
imidazole
carboxamide
oxo
lower alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57192022A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5885868A (ja
Inventor
Ee Shinetsutoraa Richaado
Shii Deeji Richaado
Maachin Gurisaa Jee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of JPS5885868A publication Critical patent/JPS5885868A/ja
Publication of JPH0435467B2 publication Critical patent/JPH0435467B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP57192022A 1981-11-04 1982-11-02 新規なイミダゾ−ルカルボキサミド誘導体類 Granted JPS5885868A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31795881A 1981-11-04 1981-11-04
US317958 1981-11-04

Publications (2)

Publication Number Publication Date
JPS5885868A JPS5885868A (ja) 1983-05-23
JPH0435467B2 true JPH0435467B2 (US20030199744A1-20031023-C00003.png) 1992-06-11

Family

ID=23235997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57192022A Granted JPS5885868A (ja) 1981-11-04 1982-11-02 新規なイミダゾ−ルカルボキサミド誘導体類

Country Status (17)

Country Link
EP (1) EP0078546B1 (US20030199744A1-20031023-C00003.png)
JP (1) JPS5885868A (US20030199744A1-20031023-C00003.png)
KR (1) KR880002709B1 (US20030199744A1-20031023-C00003.png)
AT (1) ATE23525T1 (US20030199744A1-20031023-C00003.png)
AU (1) AU556124B2 (US20030199744A1-20031023-C00003.png)
CA (1) CA1178590A (US20030199744A1-20031023-C00003.png)
DE (1) DE3274236D1 (US20030199744A1-20031023-C00003.png)
DK (1) DK488382A (US20030199744A1-20031023-C00003.png)
ES (1) ES517040A0 (US20030199744A1-20031023-C00003.png)
GB (1) GB2110668B (US20030199744A1-20031023-C00003.png)
GR (1) GR77374B (US20030199744A1-20031023-C00003.png)
IE (1) IE54512B1 (US20030199744A1-20031023-C00003.png)
IL (1) IL67132A0 (US20030199744A1-20031023-C00003.png)
NO (1) NO156450C (US20030199744A1-20031023-C00003.png)
NZ (1) NZ202351A (US20030199744A1-20031023-C00003.png)
PH (1) PH21140A (US20030199744A1-20031023-C00003.png)
ZA (1) ZA827975B (US20030199744A1-20031023-C00003.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US5002961A (en) * 1987-10-19 1991-03-26 Merrell Dow Pharmaceuticals Method for reducing injury with imidazol-2-thionecarboxamides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD140966A1 (de) * 1978-12-28 1980-04-09 Doerthe Creuzburg Mittel zur regulierung des pflanzenwachstums

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD140966A1 (de) * 1978-12-28 1980-04-09 Doerthe Creuzburg Mittel zur regulierung des pflanzenwachstums

Also Published As

Publication number Publication date
AU556124B2 (en) 1986-10-23
KR880002709B1 (ko) 1988-12-26
PH21140A (en) 1987-07-27
IL67132A0 (en) 1983-03-31
NO156450C (no) 1987-09-23
JPS5885868A (ja) 1983-05-23
CA1178590A (en) 1984-11-27
ZA827975B (en) 1983-08-31
EP0078546B1 (en) 1986-11-12
AU9011282A (en) 1983-05-12
IE54512B1 (en) 1989-11-08
ATE23525T1 (de) 1986-11-15
DK488382A (da) 1983-05-05
NZ202351A (en) 1986-02-21
ES8402825A1 (es) 1984-03-01
DE3274236D1 (de) 1987-01-02
GR77374B (US20030199744A1-20031023-C00003.png) 1984-09-11
IE822622L (en) 1983-05-04
NO156450B (no) 1987-06-15
NO823646L (no) 1983-05-05
ES517040A0 (es) 1984-03-01
GB2110668B (en) 1985-06-19
KR840002360A (ko) 1984-06-25
GB2110668A (en) 1983-06-22
EP0078546A1 (en) 1983-05-11

Similar Documents

Publication Publication Date Title
US4423044A (en) 3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof
NZ212856A (en) Glutarimide derivatives and pharmaceutical compositions
CZ398191A3 (en) Novel 4-amino alkyl-2(3h)-indolones and pharmaceutical compositions containing them
CA1215050A (en) Dihydropyridines
WO2010035727A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
US4405635A (en) 4-Aroylimidazol-2-ones and their use as pharmaceuticals
KR900000552B1 (ko) 항알레르기 및 소염 제제와 그의 제조방법
JPS6259109B2 (US20030199744A1-20031023-C00003.png)
JPS60248669A (ja) 1,3−二置換2−オキシインド−ル類
FR2880023A1 (fr) Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
US4977175A (en) 4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT3 -antagonists
JPH0435467B2 (US20030199744A1-20031023-C00003.png)
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
JPH0378854B2 (US20030199744A1-20031023-C00003.png)
JPH0699396B2 (ja) 新規オキサゾロピリジン誘導体
CZ325196A3 (en) Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process
US3960881A (en) Method for preparing 4-carboxythiazolidine-2-thione
US5109006A (en) Certain pharmaceutically active 6H-imidazo[1,2-a]pyridine-5-ones
EP0364091B1 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides
KR100382998B1 (ko) 6-메톡시-1h-벤조트리아졸-5-카르복사미드유도체,그제조방법및그것을함유하는의약조성물
US4207317A (en) 1-Aryl-4-carbamoyl-pyrazolin-5-ones
JPS606658A (ja) 三置換オキサゾリジノン化合物
IE45096B1 (en) Compositions containing thiadiazole derivatives
JPH04221386A (ja) 4H−ピロロ[1,2−a]チエノ[2,3−f][1,4]ジアゼピンの新規誘導体、それらの製造方法及びこれらを含有する医薬品組成物
JPS5911594B2 (ja) 置換ピランジオン誘導体